Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominika A Kalkowska

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 16, 2021
Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029Dominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 28, 2020
Reflections on Modeling Poliovirus Transmission and the Polio Eradication EndgameKimberly M Thompson, Dominika A Kalkowska
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 16, 2021
An Updated Economic Analysis of the Global Polio Eradication InitiativeKimberly M Thompson, Dominika A Kalkowska
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 8, 2020
Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and AfghanistanDominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 30, 2020
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast NigeriaDominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 16, 2020
Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPVDominika A Kalkowska, Kimberly M Thompson
Expert Review of Vaccines|June 29, 2019
Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)Kimberly M Thompson, Dominika A Kalkowska
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 10, 2020
Potential Future Use, Costs, and Value of Poliovirus VaccinesKimberly M Thompson, Dominika A Kalkowska
Expert Review of Vaccines|August 4, 2020
Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradicationKimberly M Thompson, Dominika A Kalkowska
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 23, 2022
Modeling undetected live type 1 wild poliovirus circulation after apparent interruption of transmission: Pakistan and AfghanistanDominika A Kalkowska, Kamran Badizadegan, Kimberly M Thompson
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 16, 2021
Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029Dominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 28, 2020
Reflections on Modeling Poliovirus Transmission and the Polio Eradication EndgameKimberly M Thompson, Dominika A Kalkowska
Risk Analysis : an Official Publication of the Society for Risk Analysis|February 16, 2021
An Updated Economic Analysis of the Global Polio Eradication InitiativeKimberly M Thompson, Dominika A Kalkowska
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 8, 2020
Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and AfghanistanDominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 30, 2020
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast NigeriaDominika A Kalkowska, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 16, 2020
Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPVDominika A Kalkowska, Kimberly M Thompson
Expert Review of Vaccines|June 29, 2019
Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)Kimberly M Thompson, Dominika A Kalkowska
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 10, 2020
Potential Future Use, Costs, and Value of Poliovirus VaccinesKimberly M Thompson, Dominika A Kalkowska
Expert Review of Vaccines|August 4, 2020
Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradicationKimberly M Thompson, Dominika A Kalkowska
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 23, 2022
Modeling undetected live type 1 wild poliovirus circulation after apparent interruption of transmission: Pakistan and AfghanistanDominika A Kalkowska, Kamran Badizadegan, Kimberly M Thompson
Pageof 5